PSD4 and breast cancer: Furthermore, PSD4 expression also decreased from the primary BC to the metastatic sample in a series of 29 matched pairs, and PSD4 downregulation was associated with poor-prognosis features and shorter DFS in a large series of non-metastatic BC.